Je Hwan Jang

Title: Je Hwan Jang: Innovator in Bioadhesive Technology

Introduction

Je Hwan Jang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of bioadhesives, particularly through his innovative patent related to extracellular matrix-based adhesives. His work is pivotal in advancing medical applications that require effective adhesion and tissue regeneration.

Latest Patents

Je Hwan Jang holds a patent for an extracellular matrix-based bioadhesive. This invention provides an adhesive composition that includes an extracellular matrix-containing hydrogel and a gelatin curing agent. The bioadhesive exhibits flowability at temperatures of 30° C. or higher, allowing for easy application to lesion sites. Notably, it demonstrates adhesive strength that is approximately 2 to 6 times greater than that of commercial fibrin glue. This technology not only serves as a bioadhesive but also incorporates components that promote wound healing and tissue regeneration.

Career Highlights

Throughout his career, Je Hwan Jang has been associated with reputable institutions such as the Postech Research and Business Development Foundation and Konkuk University Industrial Cooperation Corporation. His work in these organizations has facilitated advancements in research and development in the field of bioadhesives.

Collaborations

Je Hwan Jang has collaborated with notable colleagues, including Hyeon Ji Kim and Won Il Han. These partnerships have contributed to the successful development and application of his innovative technologies.

Conclusion

Je Hwan Jang's contributions to the field of bioadhesives highlight his role as an innovator in medical technology. His patented work on extracellular matrix-based adhesives showcases the potential for improved wound healing and tissue regeneration.